Search

Displaying results 461 to 470 of 672.

Persons

Prof Dr Yang Li

Research Group Leader
Computational Biology for Individualised Medicine
CiiM
Persons

Prof Dr Yang Li

Research Group

RNA Synthetic Biology

RNA is a ubiquitous molecule of life that plays intimate roles in how cells function and make decisions. These same properties can be harnessed to create a new generation of engineering tools to further interrogate the properties of biology and control how cells behave. The “RNA synthetic biology” group aims to better understand the roles RNA plays in biology and to exploit these roles to improve how we study, diagnose, and treat infectious diseases in humans. This department is located at the Helmholtz Institute for RNA-based Infection Research (HIRI).

Research Group

RNA Biology of bacterial infections

The Vogel lab strives to chart the diversity of noncoding RNA functions and RNA-binding proteins in major bacterial pathogens and in the hundreds of different bacteria that make up the human microbiome. We develop new RNA deep sequencing-based techniques to capture the RNA world of any microbe, ideally at the single cell level. We want to understand how and why bacteria use RNA as a regulator during infection and exploit this knowledge to target pathogens and edit the microbiota with precision. Projects focus on several bacteria from our major workhorse Salmonella Typhimurium to anaerobic microbes that are associated with colorectal cancer such as Fusobacterium nucleatum . This Department is located at the Helmholtz Institute for RNA-based Infection Research (HIRI).

Research Group

Personalised Immunotherapy

Our motivation is to address fundamental questions of human immunology and translate them into personalized therapies and diagnostics. Specifically, our laboratory discovers new applications of antibodies and B cells to treat and prevent human infectious diseases. Effective vaccines against some viruses that escape antibody responses remain elusive. To tackle this challenge, we develop methods to better understand B cell responses, the cells that produce antibodies. We design tailored vaccines and provide novel solutions for infection diagnostics. This Department is located at the Centre for Individualised Infection Medicine ( CiiM ).

Research Group

Nano Infection Biology

Viruses are nanoscale entities. Despite their size and low complexity, they efficiently enter host cells leading to infection and reprogramming of cellular functions. The critical processes involve only a handful of viral and cellular proteins. Yet this contact is critical for the outcome of infection and the cellular immune response. We look at these processes to understand which cellular processes are stimulated by viruses and how the host cell interprets an infecting virus at the molecular level. At the scale of single viruses, these processes, their dynamics and structural conditions remain mostly unclear. We thus use advanced microscopy techniques, which allow us to visualize viral and cellular nanostructures during the infection process.

Persons

Sebastian Borgert

Postdoc
Structure and Function of Proteins
HZI Campus
Research Group

Experimental Immunology

Immune cell populations are characterized by a high degree of heterogeneity to enable efficient and specialized responses to the diverse set of pathogens. This is particularly true for cells of the adaptive immune system, but also innate immune cell populations are heterogeneous and can adapt to different environmental conditions. Adaptation of immune cells is often associated with epigenetic alterations that lead to the fixation of gene expression patterns, finally resulting in cells with highly specialized fates, phenotypes and functional properties.

Persons

Alina Paukstadt

Research Group

Innovative Organoid Research

Organoids are miniature models of human organs cultivated from stem cells in laboratory settings. These delicate tissue structures mimic the three-dimensional architecture and function of real organs, offering researchers a unique opportunity to enhance their understanding of biological processes. Our aim is to advance the development of highly complex organoids incorporating immune cells and vessels. By doing so, we establish a platform, especially for investigating infections, conducting vaccine tests, and innovating therapeutic approaches.